Stay updated on IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page.

Latest updates to the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedPublication added in Publications From PubMed: Barbour et al., Kidney Int. 2025 (online ahead of print), a single-arm phase 2 trial related to IgA nephropathy. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedConsolidated location headings into a single 'Locations' section listing New South Wales, Victoria, British Columbia, and Ontario. The footer revision label updated to v3.3.3 and the 'HHS Vulnerability Disclosure' link was removed.SummaryDifference0.6%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedThe Publications section was updated to indicate PubMed auto-fills publications and may not be about the study, and to display Revision: v3.3.2. The previous PubMed note (Revision: v3.2.0) was removed.SummaryDifference0.1%

- Check54 days agoChange DetectedRemoved the generic government funding/status notice from the page. Study-specific details such as the title, NCT number, eligibility criteria, and outcome measures remain unchanged.SummaryDifference0.4%

- Check68 days agoChange DetectedThe new screenshot shows only minor layout changes and a banner variation with no changes to core trial information such as eligibility criteria, endpoints, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check97 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference5%

Stay in the know with updates to IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page.